Targeted Interference with Signal Transduction Events (Recent Results in Cancer Research, 172) - Hardcover

Hardcover

ISBN 10: 3540312080 ISBN 13: 9783540312086

Publisher: Springer, 2007

Synopsis

Sequencing of the human genome and insights into signaling pathways have contributed to the understanding of cancer etiology and the development of new, improved cancer drugs. DNA mutations of a limited set of genes are responsible for the multiple stages of tumorigenesis and metastasis. Matching of therapeutic intervention with insights into the underlying molecular disease mechanism has led to the development of drugs such as Herceptin and Glivec. The deregulation of pathways due to mutated cancer genes provides the conceptual basis for future progress. Will it be possible to extrapolate this principle and derive more efficient drugs targeting cancer pathway components? Potential drug targets have been identified, but our ability to predict the consequences of inhibition of such components is still limited. The state of development of tomorrow’s cancer drugs, directed against growth factors, growth factor receptors and intracellular signaling molecules with kinase activities, is described in this book.

Edition details

• Publisher: Springer
• Publication date: 2007
• Language: English
• ISBN 10: 3540312080
• ISBN 13: 9783540312086
• Binding: Hardcover
• Number of pages: 197
• Editor: Groner B.